Aveir Leadless Pacemaker Japan Post Marketing Surveillance
Aveir Leadless Pacemaker Japan Post Marketing Surveillance
The primary purpose of the PMS is to collect safety information on the Aveir DR leadless cardiac pacemaker (LP) system in a population indicated for de novo dual-chamber pacing. Additionally, the PMS will collect data on rollover patients from the Aveir DR i2i IDE, Aveir AR LP in patients indicated for single-chamber pacing in the right atrium, and upgradeability in patients implanted with single-chamber Aveir atrial or ventricular LP that require an upgrade to a dual-chamber Aveir LP.
Inclusion Criteria:
Exclusion Criteria:
mieko.otake@abbott.com+81-80-5866-9006
stephanie.delgado1@abbott.com
Nagoya, Aichi-ken 466-8550, Japan
inden@med.nagoya-u.ac.jp052-789-5111
Shinagawa-ku, Tokyo 142-8666, Japan
ctsc.admin@ofc.showa-u.ac.jp03-3784-8000
kenji.ando.rkc@gmail.com81935112000
ikutaro0817@marianna-u.ac.jp(044) 977-8111
kennosuke.atmm3@gmail.com
ht10970@kchnet.or.jp81-86-422-0210
kmuccr@kmu.ac.jp072-804-0101
hminamiguchi@gmail.com
t-shio@juntendo.ac.jp
masaya.shinohara@med.toho-u.ac.jp03-3762-4151
trad-project@chiba-u.jp043-222-7171
ksatomi@tokyo-med.ac.jp81333426111
yagishita.daigo@twmu.ac.jp03-3353-8111